$117.17
-0.06-0.05%
At Close: -
$117.26
0.090.07%
After Hours: 5:53 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for Merck & Co (NYSE:MRK) Stock
Merck & Co Stock (NYSE: MRK)
Categories: All
Friday, September 20, 2024
Wednesday, September 18, 2024
Tuesday, September 17, 2024
Monday, September 16, 2024
- A Closer Look at 8 Analyst Recommendations For Merck & Co
- Cantor Fitzgerald Reiterates Overweight on Me...
- NuCana's Encouraging Data From Resistant Melanoma Treatment Provides Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
- Immutep's Efti In Combination With MSD's KEYT...
- Reported Saturday, Merck And Eisai's Phase 3 ...
- Reported Saturday, Merck's KEYTRUDA Plus Chem...
- Reported Saturday, Merck's KEYTRUDA Plus Tras...
- Reported Sunday, Merck's KEYTRUDA Achieves Su...
Friday, September 13, 2024
Thursday, September 12, 2024
Wednesday, September 11, 2024
Monday, September 09, 2024
- Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
- Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
- Reported Saturday, Daiichi Sankyo And Merck's...
Thursday, September 05, 2024
Wednesday, September 04, 2024
Tuesday, September 03, 2024
- Merck's Death Cross Vs. Gilead's Golden Cross: Pharma Giants Diverge On Wall Street
- Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
- 10 Health Care Stocks With Whale Alerts In Today's Session
- (MRK) - Analyzing Merck & Co's Short Interest
- The European Commission Has Approved Merck's ...